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The Zika virus (ZIKV) is a Flavivirus that
was first isolated in rhesus macaque monkeys
in 1947 (Huang et al., 2016; Quammen, 2016).
Flaviviruses are a genus of single-stranded RNA
viruses that can cause common ailments such
as Yellow Fever, Dengue Fever, Japanese En-
cephalitis, and West Nile virus (WNV) (Cen-
ters for Disease Control and Prevention [CDC],
2017). The ZIKV is a recent headline due to
its associations with several neurological disor-
ders. Upon initial infection, symptoms are mild,
and can include headaches, fevers, muscle and
joint pain, and rashes (Quammen, 2016; CDC,
2017). In 2015, an outbreak of Zika infection in
Brazil drew researchers’ attention to the virus
(Huang et al., 2016). The outbreak concurred
with births of babies with microcephaly, a con-
genital condition characterized by small head
sizes. ZIKV-related microcephaly has been re-
lated to abnormal brain development, resulting
in mild to extreme physical and cognitive health
consequences (Huang et al., 2016).
In 2007, more than a hundred cases of ZIKV
infections were found on Yap, a small island in
the Southwestern Pacific. Two years later, the
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virus had found itself a new location in North-
eastern Brazil. ZIKV spread rapidly in Brazil
once established, and then throughout Latin
America and the Caribbean (WHO, 2017; Ven-
tura et al., 2016). Due to the perplexing number
of babies born with smaller than normal heads
coinciding with the rapid spread of ZIKV in-
fection, ZIKV and microcephaly were declared
public health emergencies in February of 2016 by
the World Health Organization (WHO) (Huang
et al., 2016).
ZIKV is primarily a concern for pregnant
women, however, if the epidemic is not dealt
with, sickness from infection can yield crippling
wage loss for individuals and their families; the
spread of the epidemic can result in economic
disruption. This paper will focus on the target
neural cells in the brain and how pathogenesis
of ZIKV causes abnormal brain development.
Moreover, the consequences of ZIKV and mi-
crocephaly in vulnerable populations will be
discussed, with included recommendations for
the prevention of infection. The paper will do
so by primarily drawing from current litera-
ture from the microbiology and virology fields,
and sociology and economics. Together, this
cross-disciplinary review will bring to light the
economic and societal impacts an epidemic can
leave behind, and emphasize the need for im-
provement to public health infrastructure.
What is ZIKA?
Under the Baltimore classification system for
viruses, which categorizes viruses depending on
their genome type (DNA or RNA) and their
method of replication, Zika is a Group IV posi-
tive single stranded RNA virus of the Flaviviri-
dae virus family (Huang et al., 2016; CDC,
2017). ZIKV is an arbovirus, as it is transmit-
ted by insects, specifically, the Aedes mosquito
that was originally found in tropical or subtrop-
ical zones, but now exists on all continents ex-
cept Antarctica (Huang et al., 2016). Members
of the Aedes genus have previously played a large
role in viral transmissions. Species Aedes aegypti
and Aedes albopictus have been recognized to
be a primary vector for ZIKV (CDC, 2017).It
was not until 2007 that ZIKV became recog-
nized as a disease causing pathogen (Posen et al.,
2016). ZIKV now joins the list of viral TORCH
pathogens because it disturbs the development of
the embryo, where TORCH stands for toxoplas-
mosis, other, rubella virus, cytomegalovirus, and
herpes simplex virus (Ming et al., 2016; Garcez
et al., 2016). TORCH factors often compro-
mise proper brain development in utero because
these pathogens can cross the blood-placental
barrier and cause congenital defects, such as mi-
crocephaly and associated, or other, cognitive
disabilities (Ming et al., 2016).
ZIKV is related to many other flaviviruses
such as the DENV, Japanese Encephalitis, and
WNV (Huang et al., 2016; CDC, 2017). Fla-
viviruses are assembled of its genomic viral RNA,
a lipid membrane, and three main structural pro-
teins (capsid (C), premembrane (M), and enve-
lope (E) protein), as shown in Figure 1 (Speer
and Pierson, 2016). ZIKV’s RNA genome en-
codes seven nonstructural proteins, proteins that
become expressed in infected cells but not in-
corporated into the virion particle, and three
structural proteins which are incorporated in
the virion particle. The encapsulation protein
is a considerable structural protein encoded by
ZIKV: it encodes an envelope glycoprotein (Env)
that is responsible for host cell surface recogni-
tion and binding (Speer and Pierson, 2016; Cox
et al., 2015). Env binds to the host cell’s en-
dosomal membrane to initiate clathrin-mediated
endocytosis. Once inside the host cell, ZIKV as-
sembles at the endoplasmic reticulum and moves
anterograde towards the Golgi Apparatus. In-
fected cells often secrete a nonstructural protein
1 (NS1), which aid in viral replication and infec-
tion of further cells (Speer and Pierson, 2016).
The target cells of the ZIKV appear to be
the neural precursor cells (NPCs) in the brain,
inducing cell death and reduced proliferation of
NPCs.
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Figure 1. Zika Virus structure displaying
genome and coded proteins – ZIKV genome con-
sists of single stranded RNA. Genome encodes
three structural proteins (premembrane (M), en-
velope (E), capsid (C)) and seven nonstructural
proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B,
NS5). Includes map of ZIKV genomic coding re-
gions (Li et al., 2016).
Neural Precursor Cells (NPCs)
Neural precursor cells (NPCs) are pluripo-
tent stem cells that have the ability to differ-
entiate into three main cell types that make up
the human central nervous system (CNS): as-
trocytes, neurons, and oligodendrocytes (Ming
et al., 2016). During neurogenesis, NPCs un-
dergo either symmetric proliferative cell division
or asymmetric differentiative cell division. Once
NPCs perform differentiation into neurons and
glial cells, they start building the neocortex of
the brain, which covers the exterior of the two
brain hemispheres. The neocortex makes up ap-
proximately two-thirds of the total brain mass
and is involved in higher learning. Some of the
neocortex functions include sensory perception,
generation of motor commands, spatial reason-
ing, conscious thought, and language (Florio and
Huttner, 2014).
ZIKV-Related Microcephaly
Microcephaly is a congenital condition char-
acterized by a decreased brain circumference
resulting in a smaller than normal head (Garcez
et al., 2016; Cohen, 2016; Ventura et al., 2016).
The smaller head circumference (Figure 2) is
usually 2 standard deviations below the mean
for the sex and age of the child (Ventural et al.,
2016). When an infant is born with a head 3
standard deviations below the mean, it is con-
sidered to be severe microcephaly and there is
a higher risk of death. Microcephaly can oc-
cur alone or with other brain abnormalities such
as vision problems, hearing loss, developmental
delays, and motor problems (Cauchemez et al.,
2016; CDC, 2017). Microcephaly can range from
mild to severe and thus, the related problems will
range from mild to severe and are often lifelong
(Cauchemez et al., 2016). The CDC (2017) re-
ports that microcephaly has a range of causes.
Some babies may acquire a mutation in their
genes, alcohol consumption during pregnancy
can induce it, and certain infections during the
mother’s pregnancy may also increase the risk of
microcephaly (CDC, 2017). As previously men-
tioned, ZIKV and microcephaly were declared
public health emergencies by the WHO in early
2016, when the two coincided during the Brazil
outbreak (Ventura et al., 2016). Infants with
microcephaly were reported among many moth-
ers infected with ZIKV during pregnancy. This
led to the CDC (2017), among other scientists,
to proclaim that there was enough evidence to
conclude that ZIKV infections during pregnancy,
especially if the mother becomes infected dur-
ing the first trimester, may cause microcephaly,
among other brain defects. The first trimester
of pregnancy appears to be more vulnerable to
brain malformations than the second or third
trimesters, as this is when brain development is
at a maximum, and the risk of brain malforma-
tions decreases as the fetus matures. Honein et
al. (2017) found that in a study of 442 completed
pregnancies, 6% had a baby with evidence of a
ZIKV-related defect, primarily microcephaly,
whereas among women infected with ZIKV dur-
ing the first trimester, 11% had a child with a
birth defect.
In ZIKV-related microcephaly, there is an
increased level of apoptosis of NPCs and corti-
cal progenitor cells (Garcez et al., 2016). Other
researchers say that ZIKV preferentially infects
and induces an apoptotic response in NPCs as
well as astrocytes, oligodendrocyte precursor
cells, and microglia. Retallack et al. (2016)
adds that, upon infection, cell lines stemming
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from the primary NPCs demonstrate a more
active apoptotic response. Because there is a
deficiency of NPCs due to apoptosis, less neu-
rons are made for the brain resulting in a smaller
than normal cortex, precipitating the cognitive
and physical impairments of microcephaly (Vo-
gel, 2016). Wu et al. found that many genes
that regulate the cell cycle were significantly
reduced upon ZIKV infection (Nguyen et al.,
2016). The cell cycle genes that were infected
were frequently interrupted and led to slower
cell growth. This slower cell growth could also
contribute to microcephaly (Vogel, 2016). Gen-
erally, ZIKV seems to downregulate the cell cycle
while upregulating apoptosis of cells of the CNS
(Ming et al., 2016; Nguyen et al., 2016).
Microcephaly currently has no cure and the
only treatment options depend on severity. In-
fants with microcephaly will often need lifelong
routine check-ups to monitor their health and
development (CDC, 2017). Some health compli-
cations of microcephaly were mentioned previ-
ously, but more could include facial distortions,
hyperactivity, seizures, and problems with bal-
ance and coordination (Mayo Clinic Staff, 2017).
Such health consequences may result in lower ed-
ucational achievements and career objectives due
to their shortfall of mental and physical capa-
bilities. Furthermore, infants with microcephaly
are believed to have a decreased life expectancy
due to their brain impairment (Coghlan, 2016).
Depending on the degree of severity, some ba-
bies will need more intensive care and treatment
throughout their life to manage their health.
Early intervention programs are available to
support coping parents such as speech therapy,
physical therapy, and seizure medications (Mayo
Clinic Staff, 2017).
Figure 2. ZIKV infected brain causing micro-
cephaly – Comparison of brain of a baby that
has developed normally (top), brain of a baby
with primary microcephaly (middle), and brain
of a baby whose mother was infected with ZIKV
(bottom). The bottom picture demonstrates a
severe reduction in brain circumference (Kader,
2016).
ZIKV Targets
The scientific consensus on the primary tar-
gets of ZIKV are cortical NPCs while neurons
are less susceptible (Li et al., 2016; Retallack et
al., 2016; Tang et al., 2016). However, NPCs,
radial glial cells, astrocytes, oligodendrocyte pre-
cursor cells, and microglia in humans all seem
to eventually succumb to ZIKV (Retallack et
al., 2016). To determine what cell types were
infected in the fetal brain, Li et al. (2016) used
apical and basal progenitor transcription factors
that play a role in embryonic development, to
verify NPCs as being the primary target in mice
brain. Apical progenitor cell markers (Sox2 and
Pax6), basal progenitor cell marker (Tbr2), and
immature neuron markers (Tuj1 and Dcx) were
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used to identify the NPC cell type while their
nuclei were stained with DAPI, after injection of
ZIKV into embryonic mice brains. Sox2, Pax6,
and Tbr2 were positive for infection whereas
the immature neuron markers were negative.
This corroborates the consensus that the ZIKV
primarily affects NPCs, by suppressing the dif-
ferentiation ability of apical and basal progenitor
cells (Li et al., 2016; Retallack et al., 2016).
In one study, slices of cortical human brain
tissue from organotypic cultures were exposed
to 3 different ZIKV strains. After 3-4 months
of fetus conception, high rates of viral infection
can be seen in the ventricular and subventric-
ular zones (VZ and SVZ) of the tissue culture
where NPCs are primarily located. The infec-
tion was contained to mainly the VZ and SVZ
with evidence of increased apoptosis in that area
as NPCs become vulnerable to cell death and
reduced proliferation when infected (Retallack
et al., 2016). When NPCs on the VZ and SVZ
are infected and undergo cell death, this gives
rise to improper neurogenesis of the subgranular
zone of the hippocampus, an area responsible
for learning and memory (Li et al., 2016). This
cell death could be a contributor of the cognitive
deficiencies associated with microcephaly. Con-
sequently, when comparing the 3 ZIKV strains,
similar margins of infection against NPCs were
observed across all 3. The infected tissue culture
was observed again at 4.5 months after con-
ception: the cortical plate (CP) and subplate
(SP) where mature neurons and post-mitotic
cells migrate to, were observed to have a higher
infection rate throughout. Glial markers GFAP
and Sox2 identified a significant infection rate
in astrocytes within the CP (Retallack et al.,
2016). These results indicate that post-mitotic
cells, such as neurons, eventually become vul-
nerable to infection (Li et al., 2016).
After the 2015 Zika outbreak in Brazil, the
Brazilian ZIKV strain was isolated and infected
into mice. Observation through transmission
electron microscope showed overt signs of viral
assembly in NPCs and eventually neurons (Cu-
gola et al., 2016). The amount of viral particles
rapidly increased over time in NPC and neuronal
cultures, suggesting that ZIKV particles are ef-
ficient replicators (Cugola et al., 2016; Retallack
et al., 2016).
Cell Cycle Disruption and Cell Death
When ZIKV infects host cells, the virus hi-
jacks the cell’s own machinery to quickly repli-
cate its own viral DNA in order to disrupt the
host’s cell cycle, or slow it down, and then kill
the cell (Vogel, 2016). It is suggested that ZIKV
inhibits NPCs from exiting the cell cycle, and
subsequent differentiation and proliferation. In-
fection not only leads to suspension of pluripo-
tent stem cells in S phase, but proliferating NPCs
exhibit a much longer S phase than those ready
for differentiation. Dysregulation of the normal
cell cycle is believed to be a contributing factor
to microcephaly among other brain abnormali-
ties (Boeuf et al., 2016; Li et al., 2016).
Several experiments have been conducted af-
ter the Brazilian epidemic to try and understand
how ZIKV and microcephaly are related. Mice
model experiments confirmed that the viral par-
ticles breached the cell cycle of NPCs, as well
as slowing their progression (Boeuf et al., 2016;
Huang et al., 2016). To find out the cause for
microcephaly in mice, Huang et al. (2016) tested
for apoptosis marker Cleaved Caspase 3 (CC3)
in brain cells using antibody-CC3 for staining.
Pervasive CC3 apoptosis activation was found
throughout the brain, with the occipital cortex
and hippocampus having a significantly higher
density (Huang et al., 2016). Embryonic mice
brains showed greater density of CC3 apoptosis
in the intermediate zone (IP) and CP before cell
death (Huang et al., 2016). In another study,
ZIKV infection led to increased cell death via
Caspase 3 activation in a culture of human NPCs
just 3 days after initial infection (Tang et al.,
2016; Cugola et al., 2016). Consequently, micro-
cephaly and other brain abnormalities resulted
as a repercussion. Death of cortical NPCs and
decreased neuronal production from viral inva-
sion are direct contributors to microcephaly, and
positive staining of CC3 apoptosis showed great
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evidence that ZIKV induced this cell death path-
way (Garcez et al., 2016; Huang et al., 2016).
Clear indications of abnormal brain develop-
ment such as microcephaly were also observed in
neurosphere models (Cugola et al., 2016; Garcez
et al., 2016). A neurosphere is a plated culture
system composed of floating clusters of neu-
ral stem cells from the brain area of interest.
Neurospheres are commonly used to observe 3D
cell growth in vitro (Jessberger et al., 2008).
Mock-infected and ZIKV-infected neurospheres
were generated by growing NPCs in suspension.
Upon examination of the ZIKV-infected model,
the neurospheres showed abnormal growth char-
acteristics and cell detachment, and grew signif-
icantly smaller, whereas the mock-infected stem
cells generated healthy, round neurospheres (Fig-
ure 3A, 3B) (Cugola et al., 2016; Garcez et al.,
2016). Most of the ZIKV-infected neurospheres
were apoptotic and died after a couple of days
(Figure 3D). It was further observed that vi-
ral particles had become bound to the host’s
membranes and gained entry into the mitochon-
dria of infected cells. Overall, this appropriately
suggests that ZIKV induces apoptosis in hu-
man NPCs and impairs proper brain formation
(Garcez et al., 2016).
Generally, in ZIKV-induced microcephaly,
there is a pattern of NPC deficiency from the
virus interrupting its cell cycle by inhibition of
the cell’s exit, and causing a cell death path-
way, ultimately leading to less neurons produced
for proper cortex development. A dire conse-
quence as mentioned before, is microcephaly.
Microcephaly patients often exhibit a signifi-
cantly smaller brain, and with that comes brain
impairments that affect motor, visual, hearing,
and cognitive functions, depending on severity
(Garcez et al., 2016).
Figure 3. ZIKV alters morphology and halts
growth of neurospheres – A) A control neuro-
sphere with normal spherical morphology after
3 days in vitro (IV). B) A ZIKV-infected neuro-
sphere with abnormal cell morphology and cell
detachment after 3 days IV. C) Mock-infected
medium plate containing normal spherical neu-
rospheres after 6 days IV. D) ZIKV-infected
medium containing very few surviving neuro-
spheres after 6 days IV (Garcez et al., 2016).
AXL Receptor
As mentioned before, ZIKV directly infects
NPC during fetal brain development to cause
cell cycle dysregulation and apoptosis (Li et al.,
2016). Research shows that NPCs express a pro-
tein that aids in ZIKV entry and infection. Axl,
a tyrosine kinase receptor that is encoded by the
Axl gene, is expressed in human NPCs (Meertens
et al., 2016; Robbins & Bender, 2016). Axl be-
longs to the TAM (Tyro3, Axl, Mertk) family of
receptor tyrosine kinases and is involved in clear-
ance of dead cells from apoptosis and regulation
of innate immunity in humans (Meertens et al.,
2016). The Axl receptor is highly abundant in
the fetal cerebral cortex, where ZIKV-susceptible
cells are expressed. NPCs, radial glial cells, as-
trocytes, microglia all express Axl in the fetal
brain (Boeuf et al., 2016; Li et al., 2016; Ming et
al., 2016). TAM receptors generally sustain cell
growth and survival. Moreover, analysis of the
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TAM genes reveal that they play a crucial role
in maintaining cortical NPCs survival, prolifer-
ation, and differentiation. For example, mice
lacking in Axl and Mertk caused early cell dif-
ferentiation and migration of NPCs in the SVZ.
This can alter the course of cells during fetal de-
velopment to result in a large array of unwanted
defects (Ji et al., 2014).
Recent studies have suggested that the Axl
receptor is the route of entry for ZIKV infec-
tion in humans (Richard et al., 2017). Axl has
previously been identified as an entry point for
DENV, a virus with similar properties to ZIKV.
DENV is also an arbovirus transmitted by the
Aedes mosquito genus of the flavivirus family.
DENV fever has similar symptoms to ZIKV
which can include muscle and joint pain, rashes,
headaches and fevers, however, there seems to be
no connection to microcephaly in DENV (Pat-
terson et al., 2016). The ZIKV virion gains
entrance into the host by binding Gas6 (Figure
4), a TAM ligand for Axl (Meertens et al., 2016;
Ming et al., 2016). Gas6 recognizes and binds
to a phosphatidylserine molecule on the viral
envelope (E) protein. Gas6 then binds to its re-
spective Axl receptor on the host. This bridges
the entry of the flavivirus into the host’s Axl pro-
tein. Recent studies concluded that TAM ligand
Gas6 is pertinent for ZIKV infection through
the Axl receptor. In one study, human microglial
cells (CHME3) were treated with the viral strain
ZIKVHD78. When TAM ligands were omitted
from the culture, ZIKV infection levels drasti-
cally declined in CHME3 cells whereas restora-
tion of Gas6 reinstated the high levels of ZIKV
infection (Figure 5), as measured by levels of
apoptosis (Meertens et al., 2016).
From here on, ZIKV enters Axl-expressing
cells through clathrin-mediated endocytosis
(Meertens et al., 2016; van der Schaar et al.,
2008). Clathrin-mediated endocytosis (CME) is
a pH-dependent pathway using clathrin-coated
vesicles to internalize ligands bound to receptors
on the target cell’s plasma membrane (Karp,
2013). CME appears to be the route of en-
try used by the majority of the flaviviruses
(Fernandez-Garcia et al., 2016; van der Schaar
et al., 2008). In a 2008 study, DENV particles
diffused from the membrane to join a clathrin-
coated pit. DENV particles mature whilst mov-
ing through the cytoplasm until membrane fu-
sion allows the viral genetic material to be re-
leased. To find out if ZIKV could enter indepen-
dently of CME, Meertens et al. (2016) treated
CHME3 with short interfering RNA to interfere
with clathrin triskelion assembly on the vesicle.
Recruitment of dynamin-2 proteins and clathrin
heavy chains were inhibited in order to interfere
with CME to see if ZIKV’s entry was affected.
After 48 hours, immunoblotting showed that
ZIKV entry was strongly impaired. Likewise,
treatment of cells with chemical and molecular
inhibitors of CME severely incapacitated the
DENV entry into mosquito cells (van der Schaar
et al., 2008).
Researchers infected astrocytes in the pres-
ence of a non-activating antibody specific for the
extracellular domain of Axl. The results con-
cluded that blocking the Axl receptor appears
to stall viral replication, however, interference
with the internal kinase activity still allowed
for astrocyte infection. This suggests that Axl’s
extracellular domain plays a role in infection
(Retallack et al., 2016). Moreover, ZIKV binds
Gas6 more efficiently than WNV or DENV and
therefore, Axl is a significant factor for infec-
tion on fetal NPCs, astrocytes, and microglia.
ZIKV’s ability to bind Gas6 and enter through
Axl may help explain why other flaviviruses can-
not cross the fetal bloodstream to cause micro-
cephaly (Richard et al., 2017). Decoy receptors
for Axl have been constructed in an attempt to
protect from flavivirus infection. One engineered
decoy is the MYD1 receptor with a high affinity
for Gas6. Results showed that MYD1 blocked
ZIKV upon infection and cells such as microglia
and astrocytes were protected. Further research
is being conducted on Axl interference, but it
is important to know that solely targeting Axl
could take a toll on innate immunity (Meertens
et al., 2016). Likewise, intercepting Axl has
been linked to overproduction of inflammatory
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cytokines, promotion of microglia activation, and
eventual death of NPCs. Therefore, blocking the
Axl protein may slow down viral replication, but
breach of normal protein function may have dire
consequences (Nowakowski et al., 2016).
Ultimately, it is suggested that ZIKV parti-
cles enter host cells via clathrin-vesicles through
tyrosine kinase receptor Axl, and are dynamin-
2 dependent as well as TAM ligand dependent
(Meertens et al., 2016).
Figure 4. ZIKV binds to a TAM ligand ZIKV
enters the cell by binding Gas6, an Axl ligand.
Gas6 recognizes and binds to a phosphatidylser-
ine molecule on the virus envelope (Meertens et
al., 2016).
Figure 5.CHME3 cells were challenged with
ZIKV in DME medium alone or containing
hGas6. Pink is control. Without Gas6 as a
ligand, % of infected cells were substantially de-
creased, as opposed to 15% infected cells with
Gas6 present.
Figure 6. Astrocytes were treated with Anti-
Gas6 ligand or control IgG and infected with
ZIKV. Using anti-viral protein antibodies, it can




A recent study suggests that microcephaly
from ZIKV may not just be caused by down-
regulation of the cell cycle and upregulation of
apoptotic genes. Retinoic acid (RA) is a small
molecule that acts as an active ingredient in vi-
tamin A. RA binds to its receptors (RAR and
RXR) on certain genes’ promoter regions to
upregulate expression of genes that coordinate
proper development of the neural tube, and other
essential embryological functions. Dysregulation
of RA signaling can cause brain malformations
and defects, such as microcephaly (Kumar et
al., 2016). For instance, previous studies where
interception of RA signaling with glyphosate
herbicides produced teratogenic effects on Xeno-
pus laevis embryos, of the African aquatic frog
family (Paganelli et al., 2010). RA has a sig-
nificant role in building the posterior-dorsal and
forebrain, therefore, disruption in the RA expres-
sion pathways from viral invasion can precipitate
abnormalities in the developing brain, such as
microcephaly (Kumar et al., 2016).
Since ZIKV is an RNA virus, it utilizes re-
verse transcriptase to synthesize a complemen-
tary DNA strand from cDNA, which is then
integrated into the host’s genome. Kumar et al.
(2016) hypothesizes that the virus inserts repeats
of a consensus sequence (5’ –AGGTCA– 3’) into
the host’s brain cells in order to disrupt the nor-
mal RA pathway. Results of the study showed
that there was greater chance for microcephaly
if the ZIKV strain contained the consensus se-
quence in its genome. Furthermore, a ZIKV
strain with more sequence repeats appeared to
be more fatal, causing congenital brain deformi-
ties, such as severe microcephaly. Nonetheless,
the authors of the study noted that a higher
number of consensus repeats could be due to
a large reading frame length in the virus, and
thus, further research is needed to investigate if
RA signaling disruption is a common cause for
brain defects.
Societal and Economic Impacts of the
ZIKV Epidemic
Outbreaks of ZIKV bring a host of societal
and economic burdens, and demonstrate moral
failures in the community. The epidemic high-
lights numerous flaws in the public health in-
frastructure, notably in poorer countries such as
Brazil. Certain demographics are more vulner-
able to the virus due to the innate social and
economic inequalities of the healthcare system,
as well as climate change. During the H1N1
Influenza outbreak in 2009, wealthier countries
received vaccines before those in immediate need
because they had had preexisting contracts with
manufacturing companies, even though their
populations were at lower risk (Gostin and Ay-
ala, 2017). The ZIKV costed the world bil-
lions and left its mark on the economy in many
countries, especially in South America and the
Caribbean (Zagorski, 2016).
The patterns of spread of ZIKV highlighted
the reality that poorer families bear much of
the consequences. In Brazil, families that re-
side in poorer parts of the country are more
susceptible to ZIKV exposure and infection due
to the crowded urban living conditions, insuffi-
cient and unkempt sewage systems, and pools of
standing water swarming with possible infectious
mosquitoes. In the United States, ZIKV has ap-
peared in states with inadequate and expensive
healthcare, where many lower-class citizens can-
not afford it, or they are unable to access these
basic healthcare resources (Sered, 2016). This
can lead to symptoms of disease being left un-
treated and may possibly precipitate into further
health consequences. Consequently, healthcare
for millions of undocumented immigrants in the
US is denied and many governors refuse to ex-
pand the insurance plan under the Affordable
Care Act (Gostin and Hodge Jr., 2016). Preg-
nant women are especially among the neglected
population of lower class citizens that cannot ac-
cess basic healthcare resources. Poorer women
often have longer waits for virus testing, blood-
work, maternal, and other health services. Since
Brazil prohibits abortion, women are forced to
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either obtain a dangerous ”back-alley” abortion,
which can lead to severe injury or even death, or
bear a child with the possibility of it having mi-
crocephaly, and the long-term impairments that
accompany it (Gostin and Ayala, 2017; Sered,
2016). Additionally, it is believed that at least
6% of ZIKV-infected mothers will miscarry or
have stillborn deliveries, whilst surviving ba-
bies will have a 13% chance of microcephaly
(Gostin and Hodge Jr., 2016). Inaccessibility to
appropriate healthcare for pregnant women and
poorer population groups further focuses on the
societal and economic inequalities that ZIKV
has brought to the surface (Gostin and Ayala,
2017).
Alternatively, the increase in global temper-
atures enhances the vulnerability of mosquito-
borne diseases, such as flaviviruses DENV,
ZIKV, and WNV (Sered, 2016). The global
changes in temperature, precipitation, and hu-
midity can escalate the mosquitoes’ reproduc-
tion rates and the number of blood meals they
must take, and prolong their breeding season,
ultimately leading to an increase in the spread
of diseases they can carry. Mercer (2016) men-
tions that each of those climate change factors
may result in more humans being exposed to
mosquitoes and therefore mosquito-borne ill-
nesses.
The World Bank estimated that the ZIKV
epidemic cost the world about US $3.6 billion in
2016. This number includes the costs of direct
expenditures, productivity loss, loss from death,
and the impacts of virus avoidance.
Firstly, direct expenditures are the costs to
directly treat and combat the disease, such as
payment for extra doctors and nurses, drugs
and treatment fees, and ultrasounds of pregnant
woman to monitor the development of the fe-
tus. (Zagorski, 2016). Former United States
President, Barack Obama, allocated $1.8 billion
towards response programs for the ZIKV out-
break: $828 million was given to the CDC and
$210 million was given to the US Department
of Health to address ZIKV complications (Lee
et al., 2017). As of August 2016, the CDC had
already spent most of its funding and was re-
questing additional funding, as the virus had
appeared in Florida. Furthermore, an additional
$81 million was relocated from biomedical re-
search for antipoverty and health care programs,
to research of ZIKV vaccinations (Tavernise,
2016).
Productivity loss comes from the inability
to work, and therefore the sickly lose out on
paid work as well as contribution to the work-
place (Constenla et al., 2016; Zagorski, 2016).
While there is no considerable economic impact
if only a handful of the population are affected
by ZIKV, it is much more potent when the epi-
demic spreads and causes mass panic such that
productivity costs can escalate. The World Bank
estimates that four million people would have
been infected in 2016 with roughly 20% of the
four million become sick. In Latin America and
the Caribbean, that would account for 750,000
people to lose out on about one week’s worth of
paid work (Zagorski, 2016).
Loss from death is the associated cost of
infection. While the World Bank and forensic
economists could not determine the value of a
life, they included the costs that are necessary
in order to make the society safer. Forensic
economists looked to alternative studies in or-
der to arrive at an estimate for the value of a
life. For example, the US Transportation De-
partment currently estimates that saving a life
is worth over $9 million when making decisions
and rules about the safety of US roads, bridges,
and tracks (Zagorski, 2016).
Lastly, disease avoidance is a large factor
in the economic impact left behind by ZIKV,
because the virus is active in many tourist coun-
tries, such as South America and the Caribbean.
The Olympic Committee forecasted around
500,000 tourists to converge in Rio de Janeiro af-
ter it was announced that Brazil would host the
2016 Summer Olympics. However, if tourists
avoided Brazil and the surrounding countries
associated with the disease, there would be po-
tential for billions of dollars to be lost without
foreign fans and athletes being present (Zagorski,
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2016). There is potential for reduced tourism
revenues to reach over $9 billion across three
years, or 0.06% of annual gross domestic product
(GDP). In that case, the Caribbean region would
require additional support from the international
community to brace the economic consequences
of ZIKV (Lesser and Kitron, 2016; The World
Bank, 2016). Similarly, after the Chikungunya
and DENV outbreak between 2006-2008, the
economic impact of three Asian economies was
assessed. There was a 4% decline in tourism rev-
enues, representing a loss of about $11 million
for Gujarat, $82 million for Malaysia, and $457
million for Thailand (Constenla et al., 2016).
The economic impacts of disease epidemics
may not always be apparent and may be sig-
nificantly underestimated, especially in diseases
like ZIKV because there can be lifelong effects
that are manifested. Since ZIKV usually does
not pose a considerable mortality risk to infected
adults, it is easy to overlook the full magnitude
of its impact.
Impacts of ZIKV-Related Microcephaly
While there is no vaccine available for ZIKV,
most infections are asymptomatic and self-
limiting, often treatable with over-the-counter
medicine, hydration, and rest (Rather et al.,
2017). However, infections to pregnant women
can implicate microcephaly, which is proba-
bly the most dramatic consequence for ZIKV-
infected newborns. Children born with micro-
cephaly are expected to have a shorter lifespan
than the average person, with the implications of
microcephaly ranging from mild to extreme. The
reality is that babies born with microcephaly
will, in most cases, require lifelong specialized
care because the underdevelopment of their brain
will have a significant effect on almost all as-
pects of their life. As previously mentioned,
microcephaly has a range of effects from vision
problems and hearing loss, to physical and cog-
nitive delays (CDC, 2017). It is predicted that
children diagnosed with microcephaly may have
an IQ below 70 (Cugola et al., 2016). Other
possible health complications of microcephaly
are speech delays, where the infant will take
longer to learn and form words and sentences
than that expected for their age. Speech ther-
apy may be required in the future if this is the
case. Children with microcephaly may develop
difficulties with balance and coordination, there-
fore long-term physiotherapy may be required
to assist them in swift use of their limbs (CDC,
2017). Because children with microcephaly may
not reach their full cognitive and physical capac-
ity, this puts them at a disadvantage, as they
are less likely to attend school which results in
lower educational achievement. Likewise, high
unemployment rates have been linked to mi-
crocephalic adults (Boeuf et al., 2016). In the
long run, resources of families caring for children
with microcephaly will be depleted as they tend
to their children’s physical and developmental
needs, such as glasses and hearing aids, physio-
therapy costs, routine check-ups, therapists, and
medication. Furthermore, the emotional toll of
lifelong supervision of a child with microcephaly
on the family can be demanding and devastating
(CDC, 2017).
Conclusion
This review examined the recent outbreak of
the Zika virus in Brazil that sparked the inter-
ests of researchers. Studies confirmed a link be-
tween ZIKV and microcephaly when the timing
of the outbreak coincided with births of babies
with smaller than normal heads. It was found
that this flavivirus targets neural precursor cells
that build the cortex of the brain. Specifically,
NPCs during the first trimester seemed to be
more susceptible to infection because this is the
period where brain development is at a maxi-
mum. ZIKV appears to disrupt the cell cycle and
induce an apoptotic response in NPCs, as can be
seen in ventricular and subventricular zones of
the brain. Recent studies show that a primary
entry way for ZIKV is through tyrosine kinase re-
ceptor Axl, however, it is important to consider
that blocking Axl can yield other severe com-
plications. Moreover, it should be noted that
recent research shows a small molecule called
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retinoic acid also being involved in infection. It
is hypothesized that ZIKV inserts repeats of a
consensus sequence into the host cell to disturb
the normal signaling pathways of RA. Finally, it
is important to consider the economic and so-
cietal impacts that an epidemic such as ZIKV
has left behind. Lower class citizens usually take
the brunt of disease because they lack access to
appropriate resources to treat the illness. These
findings emphasize the need for public health au-
thorities to provide relevant resources and funds
to vulnerable groups that face the economic and
class inequalities in society. In the meantime,
ZIKV infection can be prevented by being aware
when travelling to places where ZIKV is active,
especially if pregnant. Figure 6 shows a number
of countries where the virus is active. Also, pre-
ventative measures such as wearing long sleeves
and applying insect repellent are important when
in mosquito-rich areas.
Figure 7. ZIKV related microcephaly and
other congenital syndromes of the CNS.
Confirmed cases reported in 6 countries by
September, 2016 (Rather et al., 2017).
Limitations and Future Directions
There are several notable limitations in this
review. This review paper primarily focused on
the scientific side of ZIKV pathogenesis, and its
effect on neural precursor cells. More research
could have been conducted on the social impacts
of an infectious epidemic, especially in relation
to the Western world. This paper acknowledges
that the consequences of ZIKV span across many
disciplines, such as politics, microbiology, and
economics, and there is not one solution from
one branch of knowledge. However, it does not
propose specific initiatives to resolve the issue.
In order to control and prevent future dis-
ease epidemics, it is crucial to recognize that
this virus (along with other arthropod-borne
viruses) is spread via mosquitoes. While there
currently exists no vaccine for ZIKV, educa-
tion on prevention is the best way to hinder
mosquito bites. Intervention strategies from
public health officials to limit mosquito breeding
must be implemented. For example, in poorer
parts of the world where ZIKV is active, proper
sewage drainage systems and adequate water
management systems should be implemented
to limit reservoirs where mosquitoes can repro-
duce (Shankar et al., 2017; Rather et al., 2017).
Infected or susceptible groups should be well
educated on ZIKV’s mode of transmission to
prevent infecting others (Shankar et al., 2017;
Rather et al., 2017).
There are numerous pharmaceutical com-
panies looking to create vaccines for the virus.
Bharat Biotech in India has 2 vaccines in clin-
ical trials. Following successful animal models,
human trials should be launched to test the ef-
ficacy of vaccines. Moreover, one study showed
that antibodies derived from the mother can
be given to a fetus to stimulate short-term im-
munity. However, short-term immunity is not
sufficient, and future research on discovering
therapies that provide long-lasting immunity is
required (Shankar et al., 2017). While ZIKV is
not as big of a concern as it has been in the recent
past, it is still necessary to continue surveillance
for this devastating virus.
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